OpGen, Inc. (OPGN)

USD 1.07

(-3.6%)

Operating Expenses Summary of OpGen, Inc.

  • OpGen, Inc.'s latest annual operating expenses in 2023 was 30.65 Million USD , down -27.12% from previous year.
  • OpGen, Inc.'s latest quarterly operating expenses in 2024 Q2 was 1.61 Million USD , down -10.0% from previous quarter.
  • OpGen, Inc. reported a annual operating expenses of 21.4 Million USD in annual operating expenses 2022, down -12.86% from previous year.
  • OpGen, Inc. reported a annual operating expenses of 24.55 Million USD in annual operating expenses 2021, up 12.35% from previous year.
  • OpGen, Inc. reported a quarterly operating expenses of 1.61 Million USD for 2024 Q2, down -10.0% from previous quarter.
  • OpGen, Inc. reported a quarterly operating expenses of 15.59 Million USD for 2023 FY, down -27.12% from previous quarter.

Annual Operating Expenses Chart of OpGen, Inc. (2023 - 2012)

Historical Annual Operating Expenses of OpGen, Inc. (2023 - 2012)

Year Operating Expenses Operating Expenses Growth
2023 30.65 Million USD -27.12%
2022 21.4 Million USD -12.86%
2021 24.55 Million USD 12.35%
2020 21.86 Million USD 70.28%
2019 12.83 Million USD -10.08%
2018 14.27 Million USD -12.5%
2017 16.31 Million USD -21.34%
2016 20.74 Million USD 28.51%
2015 16.14 Million USD 84.72%
2014 8.73 Million USD -12.32%
2013 9.96 Million USD 42.85%
2012 6.97 Million USD 0.0%

Peer Operating Expenses Comparison of OpGen, Inc.

Name Operating Expenses Operating Expenses Difference
Bionano Genomics, Inc. 148.99 Million USD 79.423%
Prenetics Global Limited 60.73 Million USD 49.523%
Star Equity Holdings, Inc. 16.27 Million USD -88.409%
CareDx, Inc 277.76 Million USD 88.963%
Exact Sciences Corporation 2.06 Billion USD 98.512%
Exagen Inc. 52.29 Million USD 41.373%
Inotiv, Inc. 246.9 Million USD 87.583%
Guardant Health, Inc. 901.62 Million USD 96.6%
Biodesix, Inc. 77.41 Million USD 60.4%
BioNexus Gene Lab Corp. 3.92 Million USD -681.476%
Precipio, Inc. 13.63 Million USD -124.798%
iSpecimen Inc. 16.27 Million USD -88.348%
Natera, Inc. 938.98 Million USD 96.735%
Aspira Women's Health Inc. 24.11 Million USD -27.138%
Standard BioTools Inc. 113.48 Million USD 72.986%
23andMe Holding Co. 420.73 Million USD 92.713%
Castle Biosciences, Inc. 242.78 Million USD 87.372%
Personalis, Inc. 128.14 Million USD 76.075%
Aclaris Therapeutics, Inc. 110.52 Million USD 72.262%
Applied DNA Sciences, Inc. 16.48 Million USD -85.955%
T2 Biosystems, Inc. 41.49 Million USD 26.115%
Myriad Genetics, Inc. 600.1 Million USD 94.891%
ICON Public Limited Company 755.64 Million USD 95.943%
NeoGenomics, Inc. 341.25 Million USD 91.016%
Star Equity Holdings, Inc. 16.27 Million USD -88.409%
IDEXX Laboratories, Inc. 1.09 Billion USD 97.195%
RadNet, Inc. 268.87 Million USD 88.598%
MDxHealth SA 71.25 Million USD 56.975%
Psychemedics Corporation 11.33 Million USD -170.496%
Illumina, Inc. 3.81 Billion USD 99.196%
Check-Cap Ltd. 19.28 Million USD -58.957%
Twist Bioscience Corporation 354.18 Million USD 91.344%
DarioHealth Corp. 62.17 Million USD 50.689%
Fulgent Genetics, Inc. 171.9 Million USD 82.166%
Sera Prognostics, Inc. 39.91 Million USD 23.196%
ENDRA Life Sciences Inc. 10.52 Million USD -191.405%
OPKO Health, Inc. 574.68 Million USD 94.665%
Medpace Holdings, Inc. 187.68 Million USD 83.665%
Neogen Corporation 405.23 Million USD 92.435%
Intelligent Bio Solutions Inc. 11.7 Million USD -161.837%
Prenetics Global Limited 60.73 Million USD 49.523%
Mainz Biomed B.V. 27.15 Million USD -12.903%
bioAffinity Technologies, Inc. 8.76 Million USD -249.783%
Trinity Biotech plc 46.49 Million USD 34.062%
Neuronetics, Inc. 82.25 Million USD 62.73%
Sotera Health Company 300.46 Million USD 89.797%
bioAffinity Technologies, Inc. 8.76 Million USD -249.783%